Janux Therapeutics JANX Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Prepaid Expense and Other Assets at other companies
Other financials
Where this comes from
Reported directly by Janux Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Janux Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Janux Therapeutics's increase (decrease) in prepaid expense and other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Janux Therapeutics's increase (decrease) in prepaid expense and other assets?
- Janux Therapeutics (JANX) reported increase (decrease) in prepaid expense and other assets of $1.34M in Q1 2026.
- How has Janux Therapeutics's increase (decrease) in prepaid expense and other assets changed year-over-year?
- Janux Therapeutics's increase (decrease) in prepaid expense and other assets increased by 91.9% year-over-year, from $700K to $1.34M.
- What is the long-term trend for Janux Therapeutics's increase (decrease) in prepaid expense and other assets?
- Over 3 years (2021 to 2024), Janux Therapeutics's increase (decrease) in prepaid expense and other assets has grown at a 21.4% compound annual growth rate (CAGR), from $1.83M to $3.28M.
- What does increase (decrease) in prepaid expense and other assets mean?
- This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.